Elefant Dov 4
4 · Cellectar Biosciences, Inc. · Filed Mar 5, 2021
Insider Transaction Report
Form 4
Elefant Dov
Chief Financial Officer
Transactions
- Award
Stock option (right to buy)
2021-03-04+430,000→ 430,000 totalExercise: $1.74Exp: 2031-03-04→ Common Stock (430,000 underlying)
Footnotes (1)
- [F1]This option grant is a contingent grant subject to the following conditions: (i) approval by Cellectar's stockholders of shares available under Cellectar's equity incentive plans at Cellectar's 2021 annual meeting of stockholders or other special meeting of stockholders called for such purpose; and (ii) to the extent stockholder approval is received, the grant shall vest over a period of three years form the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date.